Navigation Links
Unique Models Help Teach Nanoscience to the Blind

At the root of scientific study are observations made with the eyes; yet in nanoscience, our eyes fail// us.

The smallest object we can see still looms thousands of times larger than a typical nano-sized structure. Even the most powerful microscopes can't peer into the nanoscale directly.

That's why nanoscale experiments offer such great opportunities to teach blind and visually impaired students about science and pique their interest in the field, says Andrew Greenberg, education and outreach coordinator for the University of Wisconsin-Madison Nanoscale Science and Engineering Center (NSEC) and the Institute for Chemical Education.

"The fact is, we're all blind at the nanoscale," he says. "So the message to blind students is, 'This is something you can do, this is a field you can enter. You have the ability to understand what's going on at the nanoscale just as much as anyone else.'"

To give blind students a feel - literally - for nanoscience and technology, Greenberg and Mohammed Farhoud, a senior biochemistry student working with UW-Madison Center for Biology Education (CBE) Director Dave Evans, are building three-dimensional models of nano-surfaces that are large enough to be explored with the hands. Their first attempt replicates "NanoBucky," a nanoscale version of the UW-Madison mascot, Bucky Badger, made entirely from tiny carbon nanofiber "hairs."

Created by UW-Madison chemistry professor Bob Hamers to demonstrate a method for controlling the growth of nanomaterials, the original NanoBucky is so tiny that approximately 9,000 of him can fit on the head of the pin. Though Greenberg and Farhoud's plaster 3-D models are several inches long and tens of thousands of times larger, they aim to faithfully reproduce every last nanofiber of Bucky's being.

"We want to get across that NanoBucky is made up of individual carbon nanofibers standing on end," says Greenberg. "If the students' finger
'"/>




Page: 1 2 3

Related medicine news :

1. Christmas, Carols And Unique Indian Christianity
2. Unique Smoking Helpline Launched In Manchester
3. Unique Smoking Helpline Launched In Manchester
4. A Unique Train To Spread Awareness About AIDS
5. A Unique Technique To Visualize How The heart functions Developed
6. Unique Cancer Rehabilitation Program Launched To Improve Cancer Care
7. Orissa Boy Invents Unique Communication Device For Paralysed
8. Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition
9. Unique Tomatoes Tops In Disease-Fighting Antioxidants
10. Unique Savings Scheme Aids Sex Workers
11. Australian City Fights Global Warming in a Unique Way
Post Your Comments:
(Date:10/13/2008)...oreValve ( www.corevalve.com ) announced today tha...g System for percutaneous aortic valve replacement... continues to enroll patients at an accelerating p...d worldwide at nearly 100 centers in 20 countries....ess Wire EON) October 13, 2008 -- During the Mond...
(Date:10/13/2008).../PRNewswire/ -- Michael Merzenich, PhD.,co-founde...as been elected,to the Institute of Medicine accor.... Merzenich is one of 65 newly elected members., ...cess that recognizes,people who have made major co...nces, health care, and public health. Election is ...
(Date:10/13/2008)...othies Given Away, FORT WORTH, Texas, Oct. 13 /PR...e third annual FitFuture KIDS Fest at the Will Rog...facturing plant in Fort Worth, passed,out thousand...ated support,for a healthier Tarrant County. The p... KIDS Fest is to help educate families about their...
(Date:10/13/2008)...Newswire-USNewswire/ -- The 2008 NCPA Digest,spon...e NCPA 110th Annual,Convention. The Digest has bee...s the most comprehensive portrait of the financial...previous calendar year. Last year,s,Digest provide...cription,drug program had played a leading role in...
Breaking Medicine News(10 mins):Health News: CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008 2Health News:Merzenich Elected to Institute of Medicine 2Health News:Merzenich Elected to Institute of Medicine 3Health News:The Dannon Company Sponsors FitFuture KIDS Fest 2Health News:The Dannon Company Sponsors FitFuture KIDS Fest 3Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 2Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 3
...earchers at The University of Texas M. D. Anderson... plays a significant role in determining// the agg...ailed in the in the October 1 issue of Clinical Ca...of an earlier research that had linked obesity to ...
...a from the extension of a Phase II study to 12 mon...ovel oral medication//, for the treatment of patie...ata, presented at the ECTRIMS/ACTRIMS meeting in T...patient groups taking FTY720 (1.25 mg and 5 mg) wh...
...betes is a chronic illness that requires continuin...on to prevent acute complications and to reduce th...ence of diabetes continues to soar, primary care p...ng tide of patients presenting with signs of diabe...
...ew study has now confirmed an ancient myth that co...e finding that it contains certain chemicals that ...rrhea//. The use of cocoa to treat diarrhea dates ...ent South American and European cultures. Until no...
Other Medicine News:Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3
(Date:10/12/2008)...N, Oct. 12 /- Boston,Scient...ults from an analysis,of nearly 7,500 patients fro...esigned to confirm the performance of the TAXUS(R)...stem in real-world practice. The,two-year pooled A...nical,restenosis in patients with diabetes as effe...
(Date:10/10/2008)...Newswire-FirstCall/ -- Inverness Medical,Innovatio...-patient,diagnostics, monitoring and health manage...e Secretary-General of the United Nations, as part...he world,s leading,research-based and generic phar...gether with senior officials from the United Natio...
(Date:10/9/2008)...s on the need to protect the eyesight of,older peo...illion people worldwide who,are blind, 80 percent ...have avoided their blindness if they had been prop...a News Release, go to:, http://www.prnewswire.com/...ye care products and equipment, is,partnering with...
(Date:10/9/2008)...swire-FirstCall/ -- Diamyd Medical reports,that th...w England Journal,of Medicine, has published an ar... Diamyd(R) diabetes vaccine for type 1 diabetes., ...314/297194 ), The article is now available on th...ill be in print on October 30. It presents the,res...
Breaking Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Alzheimers Treatment Trials May Have Special Challenges 24437 1Alzheimers Treatment Trials May Have Special Challenges 24437 2David Farhadi M D to Join Alger as Vice President Senior Analyst Co Portfolio Manager 6754 1David Farhadi M D to Join Alger as Vice President Senior Analyst Co Portfolio Manager 6754 2The kids most likely to go armed 24429 1The kids most likely to go armed 24429 2Pre eclampsia may be autoimmune disease 4220 1Pre eclampsia may be autoimmune disease 4220 2Pre eclampsia may be autoimmune disease 4220 3
...ire-FirstCall/ -- Celgene,Corporation announced th...as reported that its Data Monitoring Committee,s (...andomized clinical,trial for patients with newly d...f a low dose of dexamethasone (Decadron) in,combin...e for,patients when compared to the higher, standa...
...ire/ -- Novagali Pharma, an,emerging ophthalmic ph... announces today positive results from the Phase I...ing from Vernal,Keratoconjunctivitis (VKC). In thi...and signs of disease improved in patients,receivin...acia(R),was excellent. , VKC is a severe form of c...
Other Medicine Technology:ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
...lXpress™ kit provides a rapid method for the ...tent nucleic acids; however, the kit does not sepa...NA can be achieved by incubating the purified mate...lowed by re-extraction with ViralXpress™. The...
The Mago® Plus Automated EIA Analyzer is a fully automated, integrated ELISA system. Together, with immunosimplicity® reagents, the Mago® Plus provides a flexible, integrated solution
The Titertek MAP-C2 is designed for high throughput microplate processing. The heart of the instrument is the S60 Stacker that handles up to 60 microplates in two removable magazines. The MAP-C2 base
...imeter 4000 provides a fast, accurate assessment o...eters patented,state-of-the-art optics yield acc...moglobin as well as total hemoglobin. When,used ...imeter,4000 gives a comprehensive and complete a...
Medicine Products: